From: Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
Variables
SE
P value
Exp(B)
95% CI for Exp(B)
Overall response
0.304
0.015
2.086
1.151–3.781